speb/financial-data huggingface dataset:
DuPont ROE decomposition for CBAV3.SA (quarterly period ending 2025-09-30)
ROE: 2.8677849337970485%
Net margin: 5.842526090675032%
Asset turnover: 0.16788900075746707
Equity multiplier (leverage): 2.9236385120058173
EBIT margin: 9.370662100558006%
Interest burden factor: 0.9285433341389328
Tax burden factor: 0.6714724615196178
ROE archetype: Low Return
DuPont ROE decomposition for CBAV3.SA (quarterly period ending 2025-12-31)
ROE: -3.4843291075822345%
Net margin: -7.452738989598634%
Asset turnover: 0.15527459855258133
Equity multiplier (leverage): 3.010945137360922
EBIT margin: -6.03284627119208%
ROE archetype: Low Return
DuPont ROE decomposition for CBAV3.SA (quarterly period ending 2026-03-31)
ROE: 7.42554521717877%
Net margin: 14.797145243061257%
Asset turnover: 0.1677178193009634
Equity multiplier (leverage): 2.9920662358550385
EBIT margin: 12.460028592638112%
Interest burden factor: 1.6533183086051346
Tax burden factor: 0.7182943042501452
ROE archetype: Standard Business
DuPont ROE decomposition for CBOE (annual period ending 2022-12-31)
ROE: 6.781519637549419%
Net margin: 5.936592143488696%
Asset turnover: 0.5655888782522968
Equity multiplier (leverage): 2.0197096932444523
EBIT margin: 24.51433623847417%
Interest burden factor: 0.4461046990931575
Tax burden factor: 0.5428505428505429
ROE archetype: Standard Business
DuPont ROE decomposition for CBOE (annual period ending 2023-12-31)
ROE: 20.439445391460747%
Net margin: 20.177553994964885%
Asset turnover: 0.5209713938590678
Equity multiplier (leverage): 1.9444049232916796
EBIT margin: 28.231085199416988%
Interest burden factor: 0.9833849619825401
Tax burden factor: 0.7268041237113402
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CBOE (annual period ending 2024-12-31)
ROE: 18.51027272947269%
Net margin: 18.681157650506776%
Asset turnover: 0.5360485972009479
Equity multiplier (leverage): 1.8484379159305955
EBIT margin: 28.83624374160459%
Interest burden factor: 0.9179300415008046
Tax burden factor: 0.7057575198376084
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CBOE (annual period ending 2025-12-31)
ROE: 23.359772348400387%
Net margin: 23.333757583471215%
Asset turnover: 0.5515490453013853
Equity multiplier (leverage): 1.8150967837840708
EBIT margin: 32.117856688303426%
Interest burden factor: 1.0346740638002774
Tax burden factor: 0.7021575386186646
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CBSM.PA (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.9134666646357252
ROE archetype: Standard Business
DuPont ROE decomposition for CBSM.PA (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.890281725816892
ROE archetype: Standard Business
DuPont ROE decomposition for CBV.V (annual period ending 2022-11-30)
ROE: 11.505181353537695%
Net margin: 19.66494113581615%
Asset turnover: 0.5495727851674207
Equity multiplier (leverage): 1.064573373538237
EBIT margin: 20.76763383838517%
Interest burden factor: 0.946903305829146
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CBV.V (annual period ending 2023-11-30)
ROE: 4.353651657440966%
Net margin: 10.763322570674669%
Asset turnover: 0.38414039068822703
Equity multiplier (leverage): 1.0529732726445669
EBIT margin: -3.6733935127503203%
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CBV.V (annual period ending 2024-11-30)
ROE: -8.941771158295044%
Net margin: -22.236158728949114%
Asset turnover: 0.3842901164239156
Equity multiplier (leverage): 1.0464164795368993
EBIT margin: -14.08742362893675%
ROE archetype: Low Return
DuPont ROE decomposition for CBV.V (annual period ending 2025-11-30)
ROE: -5.297394119889994%
Net margin: -13.358615244901403%
Asset turnover: 0.3760349674818275
Equity multiplier (leverage): 1.0545631992477535
EBIT margin: -16.55134646714949%
ROE archetype: Low Return
DuPont ROE decomposition for CCAQ (quarterly period ending 2025-03-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CCAQ (quarterly period ending 2025-06-30)
ROE: 1.0890840029017281%
Asset turnover: 0
Equity multiplier (leverage): 1.0431838288257997
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CCAQ (quarterly period ending 2025-09-30)
ROE: 0.9506051139870649%
Asset turnover: 0
Equity multiplier (leverage): 1.0415195980372243
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CCAQ (quarterly period ending 2025-12-31)
ROE: 0.9175869750852726%
Asset turnover: 0
Equity multiplier (leverage): 1.0411632577959624
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CCAQ (quarterly period ending 2026-03-31)
ROE: 0.5003892964780428%
Asset turnover: 0
Equity multiplier (leverage): 1.0423838754644528
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CCC (annual period ending 2022-12-31)
ROE: 1.864852345219586%
Net margin: 4.908441199926385%
Asset turnover: 0.23350237143758387
Equity multiplier (leverage): 1.627082457297183
EBIT margin: 6.635840336993641%
Interest burden factor: 0.9603251030391742
Tax burden factor: 0.770245878625005
ROE archetype: Low Return
DuPont ROE decomposition for CCC (annual period ending 2023-12-31)
ROE: -4.668914791307217%
Net margin: -10.39627045008068%
Asset turnover: 0.27066019302523087
Equity multiplier (leverage): 1.659258274376433
EBIT margin: 6.739090789470646%
Interest burden factor: -1.4480697427465488
ROE archetype: Low Return
DuPont ROE decomposition for CCC (annual period ending 2024-12-31)
ROE: 1.6363033058931276%
Net margin: 3.306519898391194%
Asset turnover: 0.3030994225776347
Equity multiplier (leverage): 1.6327043814325668
EBIT margin: 8.478513971210837%
Interest burden factor: 0.5531989264090881
Tax burden factor: 0.7049690842623099
ROE archetype: Low Return
DuPont ROE decomposition for CCC (annual period ending 2025-12-31)
ROE: 0.08869011840761305%
Net margin: 0.15969710530075185%
Asset turnover: 0.3128772394603835
Equity multiplier (leverage): 1.7750239589419394
EBIT margin: 8.878137295991205%
Interest burden factor: 0.22941753159566078
Tax burden factor: 0.07840587115054114
ROE archetype: Low Return
DuPont ROE decomposition for CCD (quarterly period ending 2024-10-31)
Equity multiplier (leverage): 1.5939595357759218
ROE archetype: Standard Business
DuPont ROE decomposition for CCD (quarterly period ending 2025-04-30)
Equity multiplier (leverage): 1.594718530676735
ROE archetype: Standard Business
DuPont ROE decomposition for CCD (quarterly period ending 2025-10-31)
Equity multiplier (leverage): 1.5281792847028846
ROE archetype: Standard Business
DuPont ROE decomposition for CCEP.MC (annual period ending 2022-12-31)
ROE: 20.42433194574997%
Net margin: 8.78175519630485%
Asset turnover: 0.5908641217207383
Equity multiplier (leverage): 3.9362159258761924
EBIT margin: 12.892609699769054%
Interest burden factor: 0.8763994626063591
Tax burden factor: 0.7772100153295862
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CCEP.MC (annual period ending 2023-12-31)
ROE: 22.09702431171275%
Net margin: 9.119221942957054%
Asset turnover: 0.6385943995281406
Equity multiplier (leverage): 3.7944680677251843
EBIT margin: 12.725385203802864%
Interest burden factor: 0.9458995276942894
Tax burden factor: 0.7576032682705401
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CCEP.MC (annual period ending 2024-12-31)
ROE: 16.509712604471954%
Net margin: 7.065270574420198%
Asset turnover: 0.6560706382869446
Equity multiplier (leverage): 3.5617227725036305
EBIT margin: 12.40336627850083%
Interest burden factor: 0.7637080867850099
Tax burden factor: 0.7458677685950413
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CCEP.MC (annual period ending 2025-12-31)
ROE: 24.344235984707968%
Net margin: 9.468446485814077%
Asset turnover: 0.728150541115094
Equity multiplier (leverage): 3.5309880171423482
EBIT margin: 13.358212525716473%
Interest burden factor: 0.9201289398280803
Tax burden factor: 0.7703386531724407
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CCHH (annual period ending 2023-12-31)
ROE: 8.93633093908883%
Net margin: 3.770972552740972%
Asset turnover: 0.9446407861545479
Equity multiplier (leverage): 2.508644832398036
EBIT margin: 7.533525700871955%
Interest burden factor: 0.9294722333498551
Tax burden factor: 0.538540881385251
ROE archetype: Standard Business
DuPont ROE decomposition for CCHH (annual period ending 2024-12-31)
ROE: 17.916258583737854%
Net margin: 10.245269279570143%
Asset turnover: 0.8420207669037355
Equity multiplier (leverage): 2.076830923261653
EBIT margin: 14.87624033351938%
Interest burden factor: 0.9660136563650785
Tax burden factor: 0.7129300581567336
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CCHH (annual period ending 2025-12-31)
ROE: -36.30480810201575%
Net margin: -27.96060469644892%
Asset turnover: 0.7136324257718691
Equity multiplier (leverage): 1.8194620888323494
EBIT margin: -23.29166454198481%
ROE archetype: Low Return
DuPont ROE decomposition for CCM (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 4.1578687423079845
ROE archetype: Standard Business
DuPont ROE decomposition for CCM (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 4.0290637549038655
ROE archetype: Standard Business
DuPont ROE decomposition for CCM (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 3.7156715424550733
ROE archetype: Standard Business
DuPont ROE decomposition for CCR.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.3279507163858684
ROE archetype: Standard Business
DuPont ROE decomposition for CCT.L (annual period ending 2022-08-31)
ROE: 24.140058614838807%
Net margin: 5.323068899445584%
Asset turnover: 1.8964694246151201
Equity multiplier (leverage): 2.3912797573140008
EBIT margin: 6.482352807791295%
Interest burden factor: 1.00026235242676
Tax burden factor: 0.8209477181325406
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CCT.L (annual period ending 2023-08-31)
ROE: 9.318629020620186%
Net margin: 2.854206263102512%
Asset turnover: 1.5639506612373257
Equity multiplier (leverage): 2.087582366468618
EBIT margin: 4.323319003842044%
Interest burden factor: 0.8856603773584907
Tax burden factor: 0.7454196847038773
ROE archetype: Standard Business
DuPont ROE decomposition for CCT.L (annual period ending 2024-08-31)
ROE: 12.946383806761302%
Net margin: 4.012348179777829%
Asset turnover: 1.7291335862453194
Equity multiplier (leverage): 1.8660415884146793
EBIT margin: 5.303883518745088%
Interest burden factor: 0.8681637641307669
Tax burden factor: 0.8713707548829843
ROE archetype: Standard Business
DuPont ROE decomposition for CCT.L (annual period ending 2025-08-31)
ROE: -3.5159963168163237%
Net margin: -1.2372468023689842%
Asset turnover: 1.4623505083716075
Equity multiplier (leverage): 1.943303312557736
EBIT margin: 1.0560891852884091%
Interest burden factor: -1.710650329877474
ROE archetype: Low Return
DuPont ROE decomposition for CDA.AX (annual period ending 2022-06-30)
ROE: 27.377186402722064%
Net margin: 19.90259708186389%
Asset turnover: 0.8565198703065666
Equity multiplier (leverage): 1.605985498266097
EBIT margin: 22.413735194460084%
Interest burden factor: 1.1958729263261816
Tax burden factor: 0.7425239741425697
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CDA.AX (annual period ending 2023-06-30)
ROE: 17.16847645549332%
Net margin: 14.847481093964966%
Asset turnover: 0.697597779318173
Equity multiplier (leverage): 1.6575776674778044
EBIT margin: 13.779936381082573%
Interest burden factor: 1.313762897251236
Tax burden factor: 0.8201410990234398
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CDA.AX (annual period ending 2024-06-30)
ROE: 19.136913385274035%
Net margin: 14.785297360929697%
Asset turnover: 0.7553879765381196
Equity multiplier (leverage): 1.7134512783864702
EBIT margin: 14.779484030599916%
Interest burden factor: 1.2843586749431504
Tax burden factor: 0.7789049565025984
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CDA.AX (annual period ending 2025-06-30)
ROE: 21.12753890067552%
Net margin: 15.349897512110184%
Asset turnover: 0.7984248970309036
Equity multiplier (leverage): 1.7238892399495829
EBIT margin: 16.141471850685083%
Interest burden factor: 1.2303408986492694
Tax burden factor: 0.772924166156328
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CDI.PA (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 2.1890594148267817
ROE archetype: Standard Business
DuPont ROE decomposition for CDI.PA (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 2.088649924102379
ROE archetype: Standard Business
DuPont ROE decomposition for CDNA (quarterly period ending 2025-03-31)
ROE: -2.7291491476186835%
Net margin: -12.225305544075102%
Asset turnover: 0.17295430501717596
Equity multiplier (leverage): 1.290732280828472
EBIT margin: -9.463305189821101%
ROE archetype: Low Return
DuPont ROE decomposition for CDNA (quarterly period ending 2025-06-30)
ROE: -2.4247260933978003%
Net margin: -9.884747170594954%
Asset turnover: 0.18562900540210622
Equity multiplier (leverage): 1.321451666079446
EBIT margin: -12.426308563781308%
ROE archetype: Low Return
DuPont ROE decomposition for CDNA (quarterly period ending 2025-09-30)
ROE: 0.5246589716684155%
Net margin: 1.6740792564089753%
Asset turnover: 0.22828909241082226
Equity multiplier (leverage): 1.3728273637061283
EBIT margin: -0.24586477437409426%
Tax burden factor: 1.0090361445783131
ROE archetype: Low Return
DuPont ROE decomposition for CDNA (quarterly period ending 2025-12-31)
ROE: -1.337585735891938%
Net margin: -3.790157400402266%
Asset turnover: 0.2563725925006061
Equity multiplier (leverage): 1.3765525258001339
EBIT margin: -5.572675437787169%
ROE archetype: Low Return
DuPont ROE decomposition for CDNA (quarterly period ending 2026-03-31)
ROE: 0.9110723344079814%
Net margin: 2.386576040781648%
Asset turnover: 0.28557910444139806
Equity multiplier (leverage): 1.3367529628500445
EBIT margin: 1.5276125743415463%
Interest burden factor: 1.5444938820912124
Tax burden factor: 1.0115232265034209
ROE archetype: Low Return
DuPont ROE decomposition for CDRE (quarterly period ending 2025-03-31)
ROE: 2.912187226431374%
Net margin: 7.108050358938097%
Asset turnover: 0.19824377221759185
Equity multiplier (leverage): 2.066660998482186
EBIT margin: 10.952607873580005%
Interest burden factor: 0.8847719298245614
Tax burden factor: 0.733502538071066
ROE archetype: Low Return
DuPont ROE decomposition for CDRE (quarterly period ending 2025-06-30)
ROE: 3.757103605724114%
Net margin: 7.772310943357796%
Asset turnover: 0.21659302558022514
Equity multiplier (leverage): 2.2318167692785784
EBIT margin: 11.464015428778746%
Interest burden factor: 0.9554716562100938
Tax burden factor: 0.7095705735371027
ROE archetype: Low Return
DuPont ROE decomposition for CDRE (quarterly period ending 2025-09-30)
ROE: 3.2522137704099374%
Net margin: 7.0193559976647055%
Asset turnover: 0.19649516039160614
Equity multiplier (leverage): 2.3579248373298616
EBIT margin: 13.402280119844228%
Interest burden factor: 0.7105792245093346
Tax burden factor: 0.7370654810024252
ROE archetype: Low Return
DuPont ROE decomposition for CDRE (quarterly period ending 2025-12-31)
ROE: 3.5671201407521975%
Net margin: 7.019925369564177%
Asset turnover: 0.21410344884980725
Equity multiplier (leverage): 2.3733488509187484
EBIT margin: 13.093814285030858%
Interest burden factor: 0.8067683595177201
Tax burden factor: 0.6645343900367959
ROE archetype: Low Return
DuPont ROE decomposition for CDRE (quarterly period ending 2026-03-31)
ROE: 0.6040494250061169%
Net margin: 1.2706766433548435%
Asset turnover: 0.18842539582862308
Equity multiplier (leverage): 2.5228881208710545
EBIT margin: 6.004670943002915%
Interest burden factor: 0.30333226186649526
Tax burden factor: 0.6976333451077358
ROE archetype: Low Return
DuPont ROE decomposition for CDS.DE (quarterly period ending 2025-03-31)
ROE: 5.727895295416474%
Net margin: 22.020805463124393%
Asset turnover: 0.1378341298804924
Equity multiplier (leverage): 1.887144263803225
EBIT margin: 29.088287992427354%
Interest burden factor: 0.9842521646009912
Tax burden factor: 0.7691457778077663
ROE archetype: Standard Business
DuPont ROE decomposition for CDS.DE (quarterly period ending 2025-06-30)
ROE: 3.2720914626137008%
Net margin: 12.548679241140908%
Asset turnover: 0.13772036818120367
Equity multiplier (leverage): 1.8933427512280487
EBIT margin: 29.04007319821144%
Interest burden factor: 0.7576007926801281
Tax burden factor: 0.5703742244491407
ROE archetype: Low Return
DuPont ROE decomposition for CDS.DE (quarterly period ending 2025-09-30)
ROE: 5.626787019599159%
Net margin: 21.44561179171789%
Asset turnover: 0.1401339933092837
Equity multiplier (leverage): 1.8723133709730206
EBIT margin: 33.81932690885678%
Interest burden factor: 0.8674804432999254
Tax burden factor: 0.7309939584961671
ROE archetype: Standard Business
DuPont ROE decomposition for CDS.DE (quarterly period ending 2025-12-31)
ROE: 7.27310681359066%
Net margin: 26.951755208268235%
Asset turnover: 0.14581646936509396
Equity multiplier (leverage): 1.850658702282159
EBIT margin: 32.304734208541824%
Interest burden factor: 1.059618464183997
Tax burden factor: 0.7873564034477373
ROE archetype: Standard Business
DuPont ROE decomposition for CDS.DE (quarterly period ending 2026-03-31)
ROE: 5.577765510511943%
Net margin: 22.768650540624876%
Asset turnover: 0.13250521245711863
Equity multiplier (leverage): 1.8488002802342776
EBIT margin: 29.25859098370664%
Interest burden factor: 0.992504683124061
Tax burden factor: 0.7840636482341866
ROE archetype: Standard Business
DuPont ROE decomposition for CDU.LS (annual period ending 2021-12-31)
ROE: 2.9613088722805703%
Net margin: 3.702388507294411%
Asset turnover: 0.40966907637585404
Equity multiplier (leverage): 1.9523988173170466
EBIT margin: -0.45572985091779067%
Tax burden factor: 0.9647206142437134
ROE archetype: Low Return
DuPont ROE decomposition for CDU.LS (annual period ending 2022-12-31)
ROE: 3.4836180048740206%
Net margin: 3.3159460516864234%
Asset turnover: 0.5510284265535825
Equity multiplier (leverage): 1.9065538064723757
EBIT margin: 3.377754176650463%
Interest burden factor: 1.81955833154446
Tax burden factor: 0.5395273111484806
ROE archetype: Low Return
DuPont ROE decomposition for CDU.LS (annual period ending 2023-12-31)
ROE: 1.1971144508896623%
Net margin: 1.2333211468068581%
Asset turnover: 0.5008652298411308
Equity multiplier (leverage): 1.9379323451105164
EBIT margin: -0.35248338906805177%
Tax burden factor: 0.5878096443713104
ROE archetype: Low Return
DuPont ROE decomposition for CDU.LS (annual period ending 2024-12-31)
ROE: -16.823249003828444%
Net margin: -22.90938869428438%
Asset turnover: 0.32864806806561997
Equity multiplier (leverage): 2.2344224622391673
EBIT margin: -18.524751646994638%
ROE archetype: Low Return
DuPont ROE decomposition for CDU.LS (annual period ending 2025-12-31)
ROE: 4.533631802672516%
Net margin: 3.507672768045087%
Asset turnover: 0.4703291520039325
Equity multiplier (leverage): 2.7480540916667735
EBIT margin: 6.106240812849324%
Interest burden factor: 0.6341900470118649
Tax burden factor: 0.905786245441336
ROE archetype: Low Return
DuPont ROE decomposition for CDXS (annual period ending 2022-12-31)
ROE: -23.19937567767288%
Net margin: -24.238401039036006%
Asset turnover: 0.5534899138554192
Equity multiplier (leverage): 1.7292692528160114
EBIT margin: -22.88332491521755%
ROE archetype: Low Return
DuPont ROE decomposition for CDXS (annual period ending 2023-12-31)
ROE: -65.89113788394725%
Net margin: -108.69224298932181%
Asset turnover: 0.3625392165477033
Equity multiplier (leverage): 1.6721431905000606
EBIT margin: -78.12753945511312%
ROE archetype: Low Return
DuPont ROE decomposition for CDXS (annual period ending 2024-12-31)
ROE: -85.0268981776973%
Net margin: -109.9941022832589%
Asset turnover: 0.4156219797459135
Equity multiplier (leverage): 1.859895012439593
EBIT margin: -98.33010363130845%
ROE archetype: Low Return
DuPont ROE decomposition for CDXS (annual period ending 2025-12-31)
ROE: -74.87740089906008%
Net margin: -62.47460468552431%
Asset turnover: 0.4742931457373117
Equity multiplier (leverage): 2.5269718022067837
EBIT margin: -54.45891997101737%
ROE archetype: Low Return
DuPont ROE decomposition for CENTENKA.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.3382158267203812
ROE archetype: Standard Business
DuPont ROE decomposition for CENTENKA.NS (quarterly period ending 2025-03-31)
ROE: 0.4768791224295439%
Net margin: 1.5225225225225225%
Asset turnover: 0.24919460751849315
Equity multiplier (leverage): 1.2569150999964727
EBIT margin: -1.0900900900900903%
Tax burden factor: 0.7276641550053822
ROE archetype: Low Return
DuPont ROE decomposition for CENTENKA.NS (quarterly period ending 2025-06-30)
Net margin: 3.8303489153986%
EBIT margin: 1.5391128931835727%
Interest burden factor: 3.0809061488673137
Tax burden factor: 0.8077731092436974
ROE archetype: Standard Business
DuPont ROE decomposition for CENTENKA.NS (quarterly period ending 2025-09-30)
ROE: 1.5551113927753133%
Net margin: 5.463665280156594%
Asset turnover: 0.23366837043897865
Equity multiplier (leverage): 1.2180846989017418
EBIT margin: 4.426229508196721%
Interest burden factor: 1.4057490326147042
Tax burden factor: 0.8780967361384192
ROE archetype: Low Return
DuPont ROE decomposition for CENTENKA.NS (quarterly period ending 2025-12-31)
Net margin: 5.764605854488035%
EBIT margin: 6.626988946920928%
Interest burden factor: 1.159824046920821
Tax burden factor: 0.75
ROE archetype: Standard Business
DuPont ROE decomposition for CENTENKA.NS (quarterly period ending 2026-03-31)
ROE: 2.633953939231875%
Net margin: 8.148408578578373%
Asset turnover: 0.26116992546181267
Equity multiplier (leverage): 1.2376909449476885
EBIT margin: 8.437945939238517%
Interest burden factor: 1.288235294117647
Tax burden factor: 0.7496194824961949
ROE archetype: Low Return
DuPont ROE decomposition for CEPU (annual period ending 2022-12-31)
ROE: 15.895937236433658%
Net margin: 18.815924864267018%
Asset turnover: 0.5780867006574981
Equity multiplier (leverage): 1.4613949119627188
EBIT margin: 40.46737268943597%
Interest burden factor: 0.6287490408115656
Tax burden factor: 0.7395085942588181
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CEPU (annual period ending 2023-12-31)
ROE: 15.190432811006668%
Net margin: 47.212651692308945%
Asset turnover: 0.21160762571394628
Equity multiplier (leverage): 1.520479049964512
EBIT margin: 25.344725352819854%
Interest burden factor: 2.062323276568669
Tax burden factor: 0.9032626663358848
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CEPU (annual period ending 2024-12-31)
ROE: 3.3359042728813124%
Net margin: 8.298102219818993%
Asset turnover: 0.26240576784932224
Equity multiplier (leverage): 1.5320093730553626
EBIT margin: 27.41326015878649%
Interest burden factor: 0.705251138081505
Tax burden factor: 0.42921441291230483
ROE archetype: Low Return
DuPont ROE decomposition for CEPU (annual period ending 2025-12-31)
ROE: 11.632349997507779%
Net margin: 32.1524425344452%
Asset turnover: 0.25521368239435616
Equity multiplier (leverage): 1.4175863944216387
EBIT margin: 19.33727319656257%
Interest burden factor: 2.134796664462058
Tax burden factor: 0.7788650607072236
ROE archetype: Standard Business
DuPont ROE decomposition for CEV (quarterly period ending 2024-11-30)
Equity multiplier (leverage): 1.3235905270296267
ROE archetype: Standard Business
DuPont ROE decomposition for CEV (quarterly period ending 2025-05-31)
Equity multiplier (leverage): 1.3771119280983963
ROE archetype: Standard Business
DuPont ROE decomposition for CEV (quarterly period ending 2025-11-30)
Equity multiplier (leverage): 1.4758620701314478
ROE archetype: Standard Business
DuPont ROE decomposition for CFYN.L (annual period ending 2022-03-31)
ROE: 8.634937087904179%
Net margin: 1.3392697652816976%
Asset turnover: 2.650474634850745
Equity multiplier (leverage): 2.4325818433100115
EBIT margin: 2.3565610374763315%
Interest burden factor: 0.8309645631987872
Tax burden factor: 0.6839224629418472
ROE archetype: Standard Business
DuPont ROE decomposition for CFYN.L (annual period ending 2023-03-31)
ROE: 7.350250204855885%
Net margin: 1.0038739032558288%
Asset turnover: 2.6454854781515693
Equity multiplier (leverage): 2.7676908407147556
EBIT margin: 1.7885978379324337%
Interest burden factor: 0.6871247498332221
Tax burden factor: 0.8168284789644013
ROE archetype: Standard Business
DuPont ROE decomposition for CFYN.L (annual period ending 2024-03-31)
ROE: -4.039169055402518%
Net margin: -0.4593946978831215%
Asset turnover: 2.6593203656915567
Equity multiplier (leverage): 3.30624774017512
EBIT margin: 0.4490926573159751%
Interest burden factor: -1.3126593033135088
ROE archetype: Low Return
DuPont ROE decomposition for CFYN.L (annual period ending 2025-03-31)
ROE: 0.6076350763291307%
Net margin: 0.06389219643946215%
Asset turnover: 2.7722720008458865
Equity multiplier (leverage): 3.4305138654991194
EBIT margin: 1.0952429355560072%
Interest burden factor: 0.08153795160755718
Tax burden factor: 0.7154471544715448
ROE archetype: Low Return
DuPont ROE decomposition for CFYN.L (annual period ending 2026-03-31)
ROE: -4.329571596625171%
Net margin: -0.4751331000772184%
Asset turnover: 2.587394135099241
Equity multiplier (leverage): 3.5218191441289295
EBIT margin: 0.326977288933389%
Interest burden factor: -1.9446327683615818
ROE archetype: Low Return
DuPont ROE decomposition for CGI.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.1400631329283515
ROE archetype: Standard Business
DuPont ROE decomposition for CGI.L (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.138829417300956
ROE archetype: Standard Business
DuPont ROE decomposition for CGI.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.1284383957664126
ROE archetype: Standard Business
DuPont ROE decomposition for CGI.TO (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.1400631329283513
ROE archetype: Standard Business
DuPont ROE decomposition for CGI.TO (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.1388578929278803
ROE archetype: Standard Business
DuPont ROE decomposition for CGI.TO (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.12837915469319
ROE archetype: Standard Business
DuPont ROE decomposition for CGNT.V (annual period ending 2022-12-31)
ROE: -472.7697662820047%
Asset turnover: 0
Equity multiplier (leverage): 1.3607959555379205
ROE archetype: Low Return
DuPont ROE decomposition for CGNT.V (annual period ending 2023-12-31)
ROE: -492.82713378100055%
Asset turnover: 0
Equity multiplier (leverage): 2.0319769235108214
ROE archetype: Low Return
DuPont ROE decomposition for CGNT.V (annual period ending 2024-12-31)
ROE: -559.8689458168218%
Asset turnover: 0
Equity multiplier (leverage): 2.1545217742761373
ROE archetype: Low Return
DuPont ROE decomposition for CGNT.V (annual period ending 2025-12-31)
ROE: -302.37850114563224%
Asset turnover: 0
Equity multiplier (leverage): 1.4955910298081863
ROE archetype: Low Return
DuPont ROE decomposition for CGNX (quarterly period ending 2025-03-31)
ROE: 1.6327160237626832%
Net margin: 10.925493899164954%
Asset turnover: 0.11179077082933377
Equity multiplier (leverage): 1.336791346044764
EBIT margin: 12.077616693514043%
Interest burden factor: 1.0653840257550207
Tax burden factor: 0.8490898625800417
ROE archetype: Low Return
DuPont ROE decomposition for CGNX (quarterly period ending 2025-06-30)
ROE: 2.7449406017241%
Net margin: 16.263403628363704%
Asset turnover: 0.1265702314303397
Equity multiplier (leverage): 1.3334905316793628
EBIT margin: 17.436459474975212%
Interest burden factor: 1.106577947643497
Tax burden factor: 0.8428904331904623
ROE archetype: Low Return
DuPont ROE decomposition for CGNX (quarterly period ending 2025-09-30)
ROE: 1.1792930717533472%
Net margin: 6.379382575155656%
Asset turnover: 0.13822860096782785
Equity multiplier (leverage): 1.3373503226131649
EBIT margin: 20.8619245048611%
Interest burden factor: 1.088254133125595
Tax burden factor: 0.2809919984728696
ROE archetype: Low Return
DuPont ROE decomposition for CGNX (quarterly period ending 2025-12-31)
ROE: 2.19108466539238%
Net margin: 12.94454263725638%
Asset turnover: 0.12556300156370317
Equity multiplier (leverage): 1.3480647733031654
EBIT margin: 13.979662199113887%
Interest burden factor: 1.2495464338360358
Tax burden factor: 0.7410331450350507
ROE archetype: Low Return
DuPont ROE decomposition for CGNX (quarterly period ending 2026-03-31)
ROE: 3.480731233611703%
Net margin: 19.26113017207017%
Asset turnover: 0.1334785947794886
Equity multiplier (leverage): 1.353870415063601
EBIT margin: 22.30430231301944%
Interest burden factor: 1.0314666043124614
Tax burden factor: 0.8372168337192545
ROE archetype: Low Return
DuPont ROE decomposition for CGO.AX (annual period ending 2021-06-30)
ROE: 123.72819767441858%
Net margin: 10.238753909069038%
Asset turnover: 3.2536933763819587
Equity multiplier (leverage): 3.7140261627906974
EBIT margin: 13.726846283377434%
Interest burden factor: 0.9809419496166485
Tax burden factor: 0.7603841000446627
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CGO.AX (annual period ending 2022-06-30)
ROE: 34.112368556319325%
Net margin: 4.916335459737484%
Asset turnover: 2.3228808682644075
Equity multiplier (leverage): 2.9870564456409054
EBIT margin: 7.033833205303763%
Interest burden factor: 0.9748338081671414
Tax burden factor: 0.7169995129079397
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CGO.AX (annual period ending 2023-06-30)
ROE: -54.346639496379325%
Net margin: -7.322882229568804%
Asset turnover: 2.3019867146026782
Equity multiplier (leverage): 3.2239465448855573
EBIT margin: -1.055774768049483%
ROE archetype: Low Return
DuPont ROE decomposition for CGO.AX (annual period ending 2024-06-30)
ROE: -138.29879260191672%
Net margin: -5.961494596484487%
Asset turnover: 2.394112924664138
Equity multiplier (leverage): 9.689884551065623
EBIT margin: -4.503538661210331%
ROE archetype: Low Return
DuPont ROE decomposition for CGTL (annual period ending 2022-09-30)
ROE: 56.59566289046387%
Net margin: 12.228615954469376%
Asset turnover: 3.4384018418298727
Equity multiplier (leverage): 1.3460128757368297
EBIT margin: 14.507501787199558%
Interest burden factor: 1.0018846132720123
Tax burden factor: 0.8413311452981322
ROE archetype: Asset-Light Turnover Play
DuPont ROE decomposition for CGTL (annual period ending 2023-09-30)
ROE: 41.50711513562087%
Net margin: 6.2756318813979695%
Asset turnover: 5.164678399442844
Equity multiplier (leverage): 1.280624498153691
EBIT margin: 7.5465517498908135%
Interest burden factor: 1.0107555333938096
Tax burden factor: 0.8227403148154329
ROE archetype: Asset-Light Turnover Play
DuPont ROE decomposition for CGTL (annual period ending 2024-09-30)
ROE: 37.915049265109786%
Net margin: 12.025150904500343%
Asset turnover: 2.5785765845029474
Equity multiplier (leverage): 1.222759526085881
EBIT margin: 14.561290580378772%
Interest burden factor: 1.0000227556208312
Tax burden factor: 0.8258112290648231
ROE archetype: Asset-Light Turnover Play
DuPont ROE decomposition for CGTL (annual period ending 2025-09-30)
ROE: -84.84681303153808%
Net margin: -63.21381773142578%
Asset turnover: 1.2214900458668108
Equity multiplier (leverage): 1.098837778364742
EBIT margin: -62.22386225048632%
ROE archetype: Low Return
DuPont ROE decomposition for CGX.DE (annual period ending 2021-12-31)
ROE: 3.518958746105251%
Net margin: 123.9549162011173%
Asset turnover: 0.021507573311197004
Equity multiplier (leverage): 1.3199546414281322
EBIT margin: -317.96728119180636%
Tax burden factor: 0.8951102411536582
ROE archetype: Low Return
DuPont ROE decomposition for CGX.DE (annual period ending 2022-12-31)
ROE: 14.493189199215811%
Net margin: 519.9982476436761%
Asset turnover: 0.0230841920868498
Equity multiplier (leverage): 1.2073895205397804
EBIT margin: 147.85710640035384%
Interest burden factor: 4.1957803387396595
Tax burden factor: 0.8381986052884319
ROE archetype: Standard Business
DuPont ROE decomposition for CGX.DE (annual period ending 2023-12-31)
ROE: -23.198065474471967%
Net margin: -399.8740671099395%
Asset turnover: 0.03706611444858258
Equity multiplier (leverage): 1.565133789875346
EBIT margin: -57.79086982074377%
ROE archetype: Low Return
DuPont ROE decomposition for CGX.DE (annual period ending 2024-12-31)
ROE: -136.47662822375125%
Net margin: -16749.510624604816%
Asset turnover: 0.004138388984322854
Equity multiplier (leverage): 1.968905409971945
EBIT margin: -12501.606931205768%
ROE archetype: Low Return
DuPont ROE decomposition for CGX.DE (annual period ending 2025-12-31)
ROE: -0.84069081194258%
Net margin: -198.48179453165454%
Asset turnover: 0.0021915820479899394
Equity multiplier (leverage): 1.9326708163200996
EBIT margin: 288.47063927434533%
Interest burden factor: -0.688048513467229
ROE archetype: Low Return
DuPont ROE decomposition for CHC.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.3075333874418948
ROE archetype: Standard Business
DuPont ROE decomposition for CHCO (quarterly period ending 2025-03-31)
ROE: 4.011709081677985%
Net margin: 41.94533917635512%
Asset turnover: 0.010922162249001804
Equity multiplier (leverage): 8.756631973091325
Tax burden factor: 0.8218977706747569
ROE archetype: Low Return
DuPont ROE decomposition for CHCO (quarterly period ending 2025-06-30)
ROE: 4.39143442081193%
Net margin: 44.124760457278796%
Asset turnover: 0.011446103586140722
Equity multiplier (leverage): 8.694935585850128
Tax burden factor: 0.811131896698331
ROE archetype: Low Return
DuPont ROE decomposition for CHCO (quarterly period ending 2025-09-30)
ROE: 4.50216804699205%
Net margin: 44.523173864082096%
Asset turnover: 0.011915328843733069
Equity multiplier (leverage): 8.486518317406174
Tax burden factor: 0.8025361492496464
ROE archetype: Low Return
DuPont ROE decomposition for CHCO (quarterly period ending 2025-12-31)
ROE: 3.9248475248706507%
Net margin: 40.429292282472275%
Asset turnover: 0.011663038242224404
Equity multiplier (leverage): 8.323671860964316
Tax burden factor: 0.7983611947092891
ROE archetype: Low Return
DuPont ROE decomposition for CHCO (quarterly period ending 2026-03-31)
ROE: 3.956809864906145%
Net margin: 41.145353887642784%
Asset turnover: 0.011441530654257693
Equity multiplier (leverage): 8.405049031526056
Tax burden factor: 0.8082879119759564
ROE archetype: Low Return
DuPont ROE decomposition for CHG.DE (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.5722302735941978
ROE archetype: Standard Business
DuPont ROE decomposition for CHG.DE (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.9076892388346935
ROE archetype: Standard Business
DuPont ROE decomposition for CHG.L (annual period ending 2022-10-31)
ROE: 11.337000717531689%
Net margin: 11.820448877805486%
Asset turnover: 0.6466698919529108
Equity multiplier (leverage): 1.483138005261899
EBIT margin: 12.319201995012468%
Interest burden factor: 0.9696356275303644
Tax burden factor: 0.989561586638831
ROE archetype: Standard Business
DuPont ROE decomposition for CHG.L (annual period ending 2023-10-31)
ROE: 1.389686871588624%
Net margin: 1.1426153195090987%
Asset turnover: 0.7958519110306975
Equity multiplier (leverage): 1.5282156707842574
EBIT margin: 9.606432501057977%
Interest burden factor: 0.9713656387665197
Tax burden factor: 0.12244897959183675
ROE archetype: Low Return
DuPont ROE decomposition for CHG.L (annual period ending 2024-10-31)
ROE: 11.099859324104584%
Net margin: 8.089289371288144%
Asset turnover: 0.7799483808132456
Equity multiplier (leverage): 1.7593054277592441
EBIT margin: 11.591234896579973%
Interest burden factor: 0.9151943462897525
Tax burden factor: 0.7625482625482627
ROE archetype: Standard Business
DuPont ROE decomposition for CHG.L (annual period ending 2025-10-31)
ROE: 13.139373513084854%
Net margin: 9.688442211055277%
Asset turnover: 0.6435082644385146
Equity multiplier (leverage): 2.1074951144216607
EBIT margin: 14.753768844221105%
Interest burden factor: 0.9223433242506812
Tax burden factor: 0.7119645494830134
ROE archetype: Standard Business
DuPont ROE decomposition for CHI.L (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.1394534616489516
ROE archetype: Standard Business
DuPont ROE decomposition for CHI.L (quarterly period ending 2025-03-31)
Equity multiplier (leverage): 1.1424443879442203
ROE archetype: Standard Business
DuPont ROE decomposition for CHI.L (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 1.1470439806629185
ROE archetype: Standard Business
DuPont ROE decomposition for CHI.L (quarterly period ending 2026-03-31)
Equity multiplier (leverage): 1.152152638427711
ROE archetype: Standard Business
DuPont ROE decomposition for CHRS (annual period ending 2022-12-31)
Net margin: -138.24452004814208%
Asset turnover: 0.4388963641241393
EBIT margin: -121.71984723419982%
ROE archetype: Standard Business
DuPont ROE decomposition for CHRS (annual period ending 2023-12-31)
Net margin: -92.47718119761782%
Asset turnover: 0.46331445511778546
EBIT margin: -78.99076363297102%
ROE archetype: Standard Business
DuPont ROE decomposition for CHRS (annual period ending 2024-12-31)
Net margin: 108.02607146917276%
Asset turnover: 0.048952962378621644
EBIT margin: -756.5766038879837%
ROE archetype: Standard Business
DuPont ROE decomposition for CHRS (annual period ending 2025-12-31)
Net margin: 398.42549558949065%
Asset turnover: 0.11931937143148162
EBIT margin: -429.5124727307218%
ROE archetype: Standard Business
DuPont ROE decomposition for CHSR.PA (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.16636099996844
ROE archetype: Standard Business
DuPont ROE decomposition for CHSR.PA (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.1578355882265894
ROE archetype: Standard Business
DuPont ROE decomposition for CHSS.L (annual period ending 2022-12-31)
ROE: -211.58974579366964%
Net margin: -88.03668684042347%
Asset turnover: 0.47168863162731667
Equity multiplier (leverage): 5.09536755699766
EBIT margin: -88.70691619039648%
ROE archetype: Low Return
DuPont ROE decomposition for CHSS.L (annual period ending 2023-12-31)
ROE: -258.572581310267%
Net margin: -199.7490931540163%
Asset turnover: 0.40234234221796616
Equity multiplier (leverage): 3.2173767183495694
EBIT margin: -177.08182334452644%
ROE archetype: Low Return
DuPont ROE decomposition for CHSS.L (annual period ending 2024-12-31)
ROE: -216.92219929760296%
Net margin: -208.43277217005044%
Asset turnover: 0.2901808776675832
Equity multiplier (leverage): 3.586486532048469
EBIT margin: -153.81422791397853%
ROE archetype: Low Return
DuPont ROE decomposition for CHSS.L (annual period ending 2025-12-31)
ROE: -313.1027150656269%
Net margin: -180.3430317729139%
Asset turnover: 0.43510590071774935
Equity multiplier (leverage): 3.9901800615586107
EBIT margin: -131.30258550048214%
ROE archetype: Low Return
DuPont ROE decomposition for CHYM (annual period ending 2022-12-31)
ROE: -42.70986691709588%
Net margin: -46.61343050123013%
Asset turnover: 0.7115747865990856
Equity multiplier (leverage): 1.2876463498700776
EBIT margin: -47.45082956827558%
ROE archetype: Low Return
DuPont ROE decomposition for CHYM (annual period ending 2023-12-31)
ROE: -19.94570933439212%
Net margin: -15.894341216546534%
Asset turnover: 0.9338584356644946
Equity multiplier (leverage): 1.3437729902220852
EBIT margin: -18.44296435932434%
ROE archetype: Low Return
DuPont ROE decomposition for CHYM (annual period ending 2024-12-31)
ROE: -2.6733768312615473%
Net margin: -1.5146399054784376%
Asset turnover: 1.2032327456801504
Equity multiplier (leverage): 1.466902141264717
EBIT margin: -3.71721462598064%
ROE archetype: Low Return
DuPont ROE decomposition for CHYM (annual period ending 2025-12-31)
ROE: -85.5433213325106%
Net margin: -46.183915089378395%
Asset turnover: 1.2767066727930123
Equity multiplier (leverage): 1.4507889330420158
EBIT margin: -47.55776784938517%
ROE archetype: Low Return
DuPont ROE decomposition for CIA.TO (quarterly period ending 2024-12-31)
ROE: 0.12469024393737554%
Net margin: 0.45746327287250677%
Asset turnover: 0.12895665188511388
Equity multiplier (leverage): 2.1136471717301935
EBIT margin: 13.261968011729557%
Interest burden factor: 0.4229473767633539
Tax burden factor: 0.08155712746521761
ROE archetype: Low Return
DuPont ROE decomposition for CIA.TO (quarterly period ending 2025-03-31)
ROE: 2.7814957213681373%
Net margin: 9.201941953002857%
Asset turnover: 0.14309958720026175
Equity multiplier (leverage): 2.1123239632591706
EBIT margin: 19.721402626103515%
Interest burden factor: 0.8898717276238615
Tax burden factor: 0.5243415588243174
ROE archetype: Low Return
DuPont ROE decomposition for CIA.TO (quarterly period ending 2025-06-30)
ROE: 1.6844884338147033%
Net margin: 5.709361249606918%
Asset turnover: 0.13941521789665418
Equity multiplier (leverage): 2.1162663595932845
EBIT margin: 2.375539813576777%
Interest burden factor: 2.4467461600646723
Tax burden factor: 0.9822822450749598
ROE archetype: Low Return
DuPont ROE decomposition for CIA.TO (quarterly period ending 2025-12-31)
ROE: 4.3032972826544125%
Net margin: 13.756248557617997%
Asset turnover: 0.13773519593573727
Equity multiplier (leverage): 2.2712053564036485
EBIT margin: 23.338746456239452%
Interest burden factor: 0.9566818771488964
Tax burden factor: 0.616105295099378
ROE archetype: Low Return
DuPont ROE decomposition for CIA.TO (quarterly period ending 2026-03-31)
ROE: 1.5387173159323775%
Net margin: 5.5896278724409605%
Asset turnover: 0.1209812416767683
Equity multiplier (leverage): 2.275400806967043
EBIT margin: 13.6172746646609%
Interest burden factor: 0.904275471364079
Tax burden factor: 0.4539332002036101
ROE archetype: Low Return
DuPont ROE decomposition for CIE1.DE (quarterly period ending 2025-01-31)
ROE: 1.5956302385032608%
Net margin: 4.156827635088504%
Asset turnover: 0.19240603907981874
Equity multiplier (leverage): 1.9950396992316475
EBIT margin: 7.666703971051797%
Interest burden factor: 0.8344058291872954
Tax burden factor: 0.6497944426626235
ROE archetype: Low Return
DuPont ROE decomposition for CIE1.DE (quarterly period ending 2025-04-30)
ROE: 0.3220606712176723%
Net margin: 0.7966227246646618%
Asset turnover: 0.20047206850833688
Equity multiplier (leverage): 2.0166527881462715
EBIT margin: 3.090032845477041%
Interest burden factor: 0.5465938488071285
Tax burden factor: 0.47165544804375265
ROE archetype: Low Return
DuPont ROE decomposition for CIE1.DE (quarterly period ending 2025-07-31)
ROE: 1.808443332470595%
Net margin: 4.125686309082037%
Asset turnover: 0.21377447549750425
Equity multiplier (leverage): 2.0504673165962095
EBIT margin: 6.175654120724792%
Interest burden factor: 0.8740322687736538
Tax burden factor: 0.7643385648520944
ROE archetype: Low Return
DuPont ROE decomposition for CIE1.DE (quarterly period ending 2025-10-31)
ROE: 0.706555313539585%
Net margin: 1.4415111421436941%
Asset turnover: 0.2328308266840718
Equity multiplier (leverage): 2.105172475049958
EBIT margin: 8.764156972271861%
Interest burden factor: 0.024120178918052158
Tax burden factor: 6.819104268719384
ROE archetype: Low Return
DuPont ROE decomposition for CIE1.DE (quarterly period ending 2026-01-31)
ROE: 5.443378565331826%
Net margin: 10.53108457915044%
Asset turnover: 0.2427556084336294
Equity multiplier (leverage): 2.1292475968821813
EBIT margin: 13.399465467729751%
Interest burden factor: 0.9471749226006192
Tax burden factor: 0.8297656185296635
ROE archetype: Standard Business
DuPont ROE decomposition for CIE1.DE (quarterly period ending 2026-04-30)
ROE: 7.67760801451927%
Net margin: 13.892823696362031%
Asset turnover: 0.2632859999088152
Equity multiplier (leverage): 2.0989768290831536
EBIT margin: 15.195140631257006%
Interest burden factor: 0.9680906333271884
Tax burden factor: 0.9444300181770968
ROE archetype: Standard Business
DuPont ROE decomposition for CIFL.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 2.662300231231525
ROE archetype: Standard Business
DuPont ROE decomposition for CIFL.NS (quarterly period ending 2025-03-31)
ROE: -0.09049196028457736%
Net margin: -0.49444533204626423%
Asset turnover: 0.0645301407778027
Equity multiplier (leverage): 2.836149387208224
EBIT margin: -6.5727518881521325%
ROE archetype: Low Return
DuPont ROE decomposition for CIFL.NS (quarterly period ending 2025-06-30)
Net margin: -2.132177490097691%
EBIT margin: -7.701721190492586%
ROE archetype: Standard Business
DuPont ROE decomposition for CIFL.NS (quarterly period ending 2025-09-30)
ROE: 6.457987865067713%
Net margin: 35.130040576202454%
Asset turnover: 0.07970955549308094
Equity multiplier (leverage): 2.3062595715931753
EBIT margin: -7.676638155424803%
Tax burden factor: 0.8575533897364666
ROE archetype: Standard Business
DuPont ROE decomposition for CIFL.NS (quarterly period ending 2025-12-31)
Net margin: -2.0579218416103116%
EBIT margin: -6.140553943840062%
ROE archetype: Standard Business
DuPont ROE decomposition for CIFL.NS (quarterly period ending 2026-03-31)
ROE: -0.022691932185443048%
Net margin: -0.12921516014598755%
Asset turnover: 0.06570756242783556
Equity multiplier (leverage): 2.6726534558205315
EBIT margin: -17.613997127086037%
ROE archetype: Low Return
DuPont ROE decomposition for CIG (quarterly period ending 2024-09-30)
ROE: 11.688273232611175%
Net margin: 26.21509036989749%
Asset turnover: 0.19859109305315284
Equity multiplier (leverage): 2.245118301026226
Tax burden factor: 0.7208241953843653
ROE archetype: Standard Business
DuPont ROE decomposition for CIG (quarterly period ending 2024-12-31)
ROE: 3.362401514119996%
Net margin: 7.357409008382418%
Asset turnover: 0.20626514217363923
Equity multiplier (leverage): 2.215638139328172
EBIT margin: -1.5006790284342093%
Tax burden factor: 0.8636719084893627
ROE archetype: Low Return
DuPont ROE decomposition for CIG (quarterly period ending 2025-03-31)
ROE: 3.888321175176468%
Net margin: 8.757929138497275%
Asset turnover: 0.1984368435118805
Equity multiplier (leverage): 2.2373730024425313
EBIT margin: 1174.8138783585525%
Interest burden factor: 0.008710347825901164
Tax burden factor: 0.8558484349258649
ROE archetype: Low Return
DuPont ROE decomposition for CIG (quarterly period ending 2025-09-30)
ROE: 2.7728196561564697%
Net margin: 6.140732591551593%
Asset turnover: 0.20038155984555983
Equity multiplier (leverage): 2.2534279947100995
EBIT margin: 7.891377268972414%
Interest burden factor: 0.8267829429729764
Tax burden factor: 0.9411868937744603
ROE archetype: Low Return
DuPont ROE decomposition for CIG (quarterly period ending 2025-12-31)
ROE: 6.446419442347604%
Net margin: 13.249619042107904%
Asset turnover: 0.21167470566148533
Equity multiplier (leverage): 2.2985089749310883
EBIT margin: 16.87213698671369%
Interest burden factor: 0.9345367989188995
Tax burden factor: 0.8403048913006949
ROE archetype: Standard Business
DuPont ROE decomposition for CIG (quarterly period ending 2026-03-31)
Net margin: 7.325999850339075%
EBIT margin: 913.2637041513808%
Interest burden factor: 0.00859534877897219
Tax burden factor: 0.9332697807435654
ROE archetype: Standard Business
DuPont ROE decomposition for CIK (annual period ending 2022-12-31)
ROE: -15.563797250596087%
Asset turnover: -0.10101269703056606
Equity multiplier (leverage): 1.4971568269114774
ROE archetype: Low Return
DuPont ROE decomposition for CIK (annual period ending 2023-12-31)
ROE: 17.331658112218566%
Net margin: 97.74083127966888%
Asset turnover: 0.12312144495878362
Equity multiplier (leverage): 1.4402251195540599
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CIK (annual period ending 2024-12-31)
ROE: 9.39731606217675%
Net margin: 95.20100383255064%
Asset turnover: 0.06951135168756953
Equity multiplier (leverage): 1.420059600789028
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CIK (annual period ending 2025-12-31)
ROE: 5.001680317433373%
Net margin: 81.16929361965578%
Asset turnover: 0.041121107809962816
Equity multiplier (leverage): 1.498509007104744
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CIN.AX (annual period ending 2022-06-30)
ROE: 4.12041066177772%
Net margin: 94.94838691530954%
Asset turnover: 0.036276794605978484
Equity multiplier (leverage): 1.196255659049658
Tax burden factor: 0.9718999222641292
ROE archetype: Low Return